LINC01635, a long non‑coding RNA with a cancer/testis expression pattern, promotes lung cancer progression by sponging miR‑455‑5p

Shen,Wenyi; Pu,Juan; Gu,Shanye; Sun,Jing; Wang,Lili; Tan,Bin; Chen,Jianmeng; Zuo,Yangsong

doi:10.3892/ol.2022.13558

LINC01635, a long non‑coding RNA with a cancer/testis expression pattern, promotes lung cancer progression by sponging miR‑455‑5p

Authors:
- Wenyi Shen
- Juan Pu
- Shanye Gu
- Jing Sun
- Lili Wang
- Bin Tan
- Jianmeng Chen
- Yangsong Zuo
View Affiliations

Affiliations: Department of Respiratory Medicine, Lianshui County People's Hospital, Kangda College of Nanjing Medical University, Huai'an, Jiangsu 223400, P.R. China, Department of Radiotherapy, Lianshui County People's Hospital, Kangda College of Nanjing Medical University, Huai'an, Jiangsu 223400, P.R. China, Clinical Laboratory, Lianshui County People's Hospital, Kangda College of Nanjing Medical University, Huai'an, Jiangsu 223400, P.R. China
Published online on: October 21, 2022 https://doi.org/10.3892/ol.2022.13558
Article Number: 438
Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) have been reported to play vital roles in human lung cancer. In recent years, cancer/testis (CT) lncRNAs have been characterized as a novel class of lncRNA. However, this class of lncRNA remains to be thoroughly investigated. The present study identified long intergenic non‑protein coding RNA 1635 (LINC01635), which was highly expressed in testis and in a broad range of human cancer types. Next, it was confirmed that LINC01635 was upregulated significantly in samples from patients with lung cancer and in non‑small cell lung carcinoma (NSCLC) cell lines. Silencing LINC01635 suppressed the proliferation and metastasis of NSCLC cells in vitro and in vivo. Furthermore, it was found that LINC01635 could bind to microRNA (miRNA or miR)‑455‑5p and regulate the expression of a series of miR‑455‑5p‑targeting tumor‑related genes. Knockdown of miR‑455‑5p partially rescued the progression of lung cancer cells that was suppressed by LINC01635 silencing. Together, the current results demonstrated that LINC01635 may play important roles in NSCLC progression by targeting miR‑455‑5p, and that it could be a biomarker and therapeutic target for lung cancer.

View Figures

View References

1	Bade BC and Dela Cruz CS: Lung cancer 2020: Epidemiology, etiology, and prevention. Clin Chest Med. 41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI
2	Venkatesan P: IASLC 2020 world conference on lung cancer. Lancet Respir Med. 8:e762020. View Article : Google Scholar : PubMed/NCBI
3	Herbst RS, Morgensztern D and Boshoff C: The biology and management of non-small cell lung cancer. Nature. 553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
4	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
5	Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current therapies and new targeted treatments. Lancet. 389:299–311. 2017. View Article : Google Scholar : PubMed/NCBI
6	Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al: The transcriptional landscape of the mammalian genome. Science. 309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
7	Nagano T and Fraser P: No-nonsense functions for long noncoding RNAs. Cell. 145:178–181. 2011. View Article : Google Scholar : PubMed/NCBI
8	Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
9	Wang L, Chen Z, An L, Wang Y, Zhang Z, Guo Y and Liu C: Analysis of long non-coding RNA expression profiles in non-small cell lung cancer. Cell Physiol Biochem. 38:2389–2400. 2016. View Article : Google Scholar : PubMed/NCBI
10	Qiu M, Feng D, Zhang H, Xia W, Xu Y, Wang J, Dong G, Zhang Y, Yin R and Xu L: Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma. Oncotarget. 7:16012–16022. 2016. View Article : Google Scholar : PubMed/NCBI
11	Chen J, Wang R, Zhang K and Chen LB: Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
12	Xu YJ, Du Y and Fan Y: Long noncoding RNAs in lung cancer: What we know in 2015. Clin Transl Oncol. 18:660–665. 2016. View Article : Google Scholar : PubMed/NCBI
13	Chen Z, Lei T, Chen X, Gu J, Huang J, Lu B and Wang Z: Long non-coding RNA in lung cancer. Clin Chim Acta. 504:190–200. 2020. View Article : Google Scholar : PubMed/NCBI
14	Whitehurst AW: Cause and consequence of cancer/testis antigen activation in cancer. Annu Rev Pharmacol Toxicol. 54:251–272. 2014. View Article : Google Scholar : PubMed/NCBI
15	Babatunde KA, Najafi A, Salehipour P, Modarressi MH and Mobasheri MB: Cancer/testis genes in relation to sperm biology and function. Iran J Basic Med Sci. 20:967–974. 2017.PubMed/NCBI
16	Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J, Poliakov A, et al: Oncogenic role of THOR, a conserved cancer/testis long non-coding RNA. Cell. 171:1559–1572. e202017. View Article : Google Scholar : PubMed/NCBI
17	Qin N, Wang C, Lu Q, Ma Z, Dai J, Ma H, Jin G, Shen H and Hu Z: Systematic identification of long non-coding RNAs with cancer-testis expression patterns in 14 cancer types. Oncotarget. 8:94769–94779. 2017. View Article : Google Scholar : PubMed/NCBI
18	Chen S, Chen Y, Qian Q, Wang X, Chang Y, Ju S, Xu Y, Zhang C, Qin N, Ding H, et al: Gene amplification derived a cancer-testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma. Cancer Med. 8:3017–3025. 2019. View Article : Google Scholar : PubMed/NCBI
19	Tan X, Shao Y, Teng Y, Liu S, Li W, Xue L, Cao Y, Sun C, Zhang J, Han J, et al: The cancer-testis long non-coding RNA PCAT6 facilitates the malignant phenotype of ovarian cancer by sponging miR-143-3p. Front Cell Dev Biol. 9:5936772021. View Article : Google Scholar : PubMed/NCBI
20	Roth A, Boulay K, Groß M, Polycarpou-Schwarz M, Mallette FA, Regnier M, Bida O, Ginsberg D, Warth A, Schnabel PA, et al: Targeting LINC00673 expression triggers cellular senescence in lung cancer. RNA Biol. 15:1499–1511. 2018. View Article : Google Scholar : PubMed/NCBI
21	Mitchell KA, Zingone A, Toulabi L, Boeckelman J and Ryan BM: Comparative transcriptome profiling reveals coding and noncoding RNA differences in NSCLC from African Americans and European Americans. Clin Cancer Res. 23:7412–7425. 2017. View Article : Google Scholar : PubMed/NCBI
22	Zheng Y, Xu Q, Liu M, Hu H, Xie Y, Zuo Z and Ren J: lnCAR: A comprehensive resource for lncRNAs from cancer arrays. Cancer Res. 79:2076–2083. 2019. View Article : Google Scholar : PubMed/NCBI
23	Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
24	Czimmerer Z, Hulvely J, Simandi Z, Varallyay E, Havelda Z, Szabo E, Varga A, Dezso B, Balogh M, Horvath A, et al: A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules. PLoS One. 8:e551682013. View Article : Google Scholar : PubMed/NCBI
25	Hu R, Fan C, Li H, Zhang Q and Fu YF: Evaluation of putative reference genes for gene expression normalization in soybean by quantitative real-time RT-PCR. BMC Mol Biol. 10:932009. View Article : Google Scholar : PubMed/NCBI
26	Lawson ND and Weinstein BM: In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 248:307–318. 2002. View Article : Google Scholar : PubMed/NCBI
27	Fior R, Póvoa V, Mendes RV, Carvalho T, Gomes A, Figueiredo N and Ferreira MG: Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci USA. 114:E8234–E8243. 2017. View Article : Google Scholar : PubMed/NCBI
28	Hason M and Bartůněk P: Zebrafish models of cancer-new insights on modeling human cancer in a non-mammalian vertebrate. Genes (Basel). 10:9352019. View Article : Google Scholar : PubMed/NCBI
29	Chen Y and Wang X: miRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 48:D127–D131. 2020. View Article : Google Scholar : PubMed/NCBI
30	Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P, Floros E, Dalamagas T, et al: DIANA-LncBase v2: Indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 44:D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
31	Xing Q, Xie H, Zhu B, Sun Z and Huang Y: MiR-455-5p suppresses the progression of prostate cancer by targeting CCR5. Biomed Res Int. 2019:63947842019. View Article : Google Scholar : PubMed/NCBI
32	Xu M, Fang S, Song J, Chen M, Zhang Q, Weng Q, Fan X, Chen W, Wu X, Wu F, et al: CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance. Cell Death Dis. 9:9572018. View Article : Google Scholar : PubMed/NCBI
33	Shi-Peng G, Chun-Lin C, Huan W, Fan-Liang M, Yong-Ning C, Ya-Di Z, Guang-Ping Z and Ye-Ping C: TMED2 promotes epithelial ovarian cancer growth. Oncotarget. 8:94151–94165. 2017. View Article : Google Scholar : PubMed/NCBI
34	Jin K, Zhao W, Xie X, Pan Y, Wang K and Zhang H: MiR-520b restrains cell growth by targeting HDAC4 in lung cancer. Thorac Cancer. 9:1249–1254. 2018. View Article : Google Scholar : PubMed/NCBI
35	Huang N, Lin W, Shi X and Tao T: STK24 expression is modulated by DNA copy number/methylation in lung adenocarcinoma and predicts poor survival. Future Oncol. 14:2253–2263. 2018. View Article : Google Scholar : PubMed/NCBI
36	Belletti B and Baldassarre G: Roles of CDKN1B in cancer? Aging (Albany NY). 7:529–530. 2015. View Article : Google Scholar : PubMed/NCBI
37	Shen T, Cai LD, Liu YH, Li S, Gan WJ, Li XM, Wang JR, Guo PD, Zhou Q, Lu XX, et al: Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy. J Hematol Oncol. 11:952018. View Article : Google Scholar : PubMed/NCBI
38	Wu Y, Qin J, Li F, Yang C, Li Z, Zhou Z, Zhang H, Li Y, Wang X, Liu R, et al: USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5. J Biol Chem. 294:17837–17847. 2019. View Article : Google Scholar : PubMed/NCBI
39	Gong T, Zhou B, Liu M, Chen X, Huang S, Xu Y, Luo R and Chen Z: RAB18 promotes proliferation and metastasis in hepatocellular carcinoma. Am J Transl Res. 11:1009–1019. 2019.PubMed/NCBI
40	Huang J, Ji EH, Zhao X, Cui L, Misuno K, Guo M, Huang Z, Chen X and Hu S: Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. J Exp Clin Cancer Res. 38:1382019. View Article : Google Scholar : PubMed/NCBI
41	Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and De W: The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 13:4642013. View Article : Google Scholar : PubMed/NCBI
42	Tang Y, Xiao G, Chen Y and Deng Y: LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Anticancer Drugs. 29:725–735. 2018. View Article : Google Scholar : PubMed/NCBI
43	Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
44	Scanlan MJ, Simpson AJ and Old LJ: The cancer/testis genes: Review, standardization, and commentary. Cancer Immun. 4:12004.PubMed/NCBI
45	Gordeeva O: Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Semin Cancer Biol. 53:75–89. 2018. View Article : Google Scholar : PubMed/NCBI
46	Bridges MC, Daulagala AC and Kourtidis A: LNCcation: lncRNA localization and function. J Cell Biol. 220:e2020090452021. View Article : Google Scholar : PubMed/NCBI
47	Melé M and Rinn JL: ‘Cat's Cradling’ the 3D genome by the Act of LncRNA transcription. Mol Cell. 62:657–664. 2016. View Article : Google Scholar : PubMed/NCBI
48	Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
49	Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
50	Razavipour SF, Harikumar KB and Slingerland JM: p27 as a transcriptional regulator: New roles in development and cancer. Cancer Res. 80:3451–3458. 2020. View Article : Google Scholar : PubMed/NCBI
51	Tsang SM, Oliemuller E and Howard BA: Regulatory roles for SOX11 in development, stem cells and cancer. Semin Cancer Biol. 67:3–11. 2020. View Article : Google Scholar : PubMed/NCBI
52	Liu J, Zhang J, Li Y, Wang L, Sui B and Dai D: MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18. Gene. 592:308–315. 2016. View Article : Google Scholar : PubMed/NCBI
53	Lim W, Ridge CA, Nicholson AG and Mirsadraee S: The 8 th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 8:709–718. 2018. View Article : Google Scholar : PubMed/NCBI